
Randhir Kaboo MD
Pain Medicine, Pediatric Pain Medicine
Physician
Join to View Full Profile
18300 Highway 18Apple Valley, CA 92307
Phone+1 760-242-2311
Fax+1 760-242-9167
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Randhir Kaboo, MD is a board certified anesthesiologist in Apple Valley, California. He is currently licensed to practice medicine in California.
Education & Training
University of MarylandFellowship, Pain Medicine, 2002 - 2003
University of MarylandResidency, Anesthesiology, 1999 - 2002
IM Sechenov Moscow Medical AcademyClass of 1990
Moscow Medical AcademyClass of 1990
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Anesthesiology Anesthesiology
American Board of Anesthesiology Pain Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage Stage 1 Certification eHR Meaningful Use for Medical Imaging, DR Systems, Inc., 2014-2015
- CMS Meaningful Use Stage Stage 1 Certification eHR Meaningful Use, DR Systems, Inc., 2014-2015
Publications & Presentations
PubMed
- 56 citationsPresentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer va...Peter F.A. Mulders, Cho-Lea Tso, Barbara J. Gitlitz, Randhir Kaboo, Andreas Hinkel
Clinical Cancer Research. 1999-02-01 - 7 citationsAdenovirus-mediated interleukin-2 production by tumors induces growth of cytotoxic tumor-infiltrating lymphocytes against human renal cell carcinoma.Peter F.A. Mulders, Cho-Lea Tso, Shen Pang, Randhir Kaboo, William H. McBride
Journal of Immunotherapy. 1998-05-01 - 25 citationsHighly efficient and consistent gene transfer into dendritic cells utilizing a combination of ultraviolet-irradiated adenovirus and poly(L-lysine) conjugates.Peter F.A. Mulders, Shen Pang, Jens Dannull, Randhir Kaboo, Andreas Hinkel
Cancer Research. 1998-03-01









